A metastatic breast cancer survivor shares how exercise gave her a sense of control while emphasizing why it should never be used to blame people with cancer.
|Articles|August 14, 2009
FDA panel partially backs new bone loss drug
Author(s)Melissa Weber
Advertisement
An advisory committee for the FDA has recommended that the agency approve denosumab for the treatment of bone loss in patients undergoing hormone ablation for prostate cancer and for the treatment of postmenopausal osteoporosis. The committee gave the thumbs down, however, for the drug's use to treat or prevent bone loss in women with breast cancer undergoing hormone ablation, saying additional data are needed.The FDA, which typically follows the advice of its committees, will decide whether to approve the drug by mid-October. Check out
Advertisement
Related to this article
A long-term metastatic ovarian cancer survivor explains how a trifecta of hope, purpose and grace has shaped her life through years of treatment.
Six-year PERSEUS results show 81% of newly diagnosed, transplant-eligible myeloma patients had no cancer progression, with many stopping Darzalex.
A phase 3 trial found that adding Imdelltra to Imfinzi maintenance improved survival in extensive-stage small cell lung cancer, while another drug's application was pulled. Here's what patients should know.
Living with metastatic breast cancer can make Pinktober feel complicated. One patient reflects on awareness, research, loss and remembering the people behind the pink.
A leukemia survivor recalls how bonding with other patients helped his hospital stays go by faster and became a key part of his emotional healing.
Learn how nipple-sparing mastectomy, including endoscopic approaches, may help preserve appearance, reduce scarring and support breast cancer recovery.
After 17 and a half years with metastatic primary peritoneal cancer, a former hospital executive explains how an AI health agent helped her after discharge.
Advertisement
Advertisement
Trending on CURE
1
5 Years of Breast Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
Radiation Oncologist Answers Top Questions About Radiation Therapy
3
10 Cancer Treatment Approvals From September 2026 and What They Mean for You
4
Beyond Pinktober: What Breast Cancer Awareness Means With Metastatic Breast Cancer
5